KNApSAcK Metabolite C00001490
Metabolite
KNApSAcK Entry
| id | C00001490 |
|---|---|
| Name | Adenine |
| CAS RN | 73-24-5 |
| Standard InChI | InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10) |
| Standard InChI (Main Layer) | InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10) |
Cluster
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 6151 |
Link
ChEMBL
| By standard InChI | CHEMBL226345 |
|---|---|
| By standard InChI Main Layer | CHEMBL226345 |
KEGG
| By LinkDB | C00147 |
|---|
CTD
| By CAS RN | D000225 |
|---|
Species
Summary
Plant class
| class name | count |
|---|---|
| rosids | 2 |
| Liliopsida | 1 |
| Magnoliophyta | 1 |
Family
| family name | count |
|---|---|
| Fabaceae | 2 |
| Tricholomataceae | 1 |
| Asparagaceae | 1 |
| Annonaceae | 1 |
List (5)
* NCBI
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Annona purpurea | 1123437 | Annonaceae | Magnoliophyta | Viridiplantae |
| Cicer arietinum | 3827 | Fabaceae | rosids | Viridiplantae |
| Disporopsis aspera | 100534 | Asparagaceae | Liliopsida | Viridiplantae |
| Oxytropis glabra | 483874 | Fabaceae | rosids | Viridiplantae |
| Pleurocybella porrigens | 71910 | Tricholomataceae | Fungi |
Human Protein / Gene in interaction
52 ChEMBL Protein in interactions
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL226345 |
CHEMBL830657
(1)
|
1 / 1 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | CHEMBL226345 |
CHEMBL1664429
(1)
|
0 / 0 |
| P08069 | Insulin-like growth factor 1 receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL226345 |
CHEMBL1819993
(1)
|
1 / 3 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL226345 |
CHEMBL830639
(1)
CHEMBL1819997
(1)
|
0 / 0 |
| P22894 | Neutrophil collagenase | M10A | CHEMBL226345 |
CHEMBL1664434
(1)
|
0 / 0 |
| P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | CHEMBL226345 |
CHEMBL1820089
(1)
|
9 / 1 |
| P45984 | Mitogen-activated protein kinase 9 | Jnk | CHEMBL226345 |
CHEMBL832006
(1)
|
0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | CHEMBL226345 |
CHEMBL831280
(1)
|
0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL226345 |
CHEMBL832021
(1)
|
0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL226345 |
CHEMBL1664435
(1)
|
2 / 2 |
| Q15303 | Receptor tyrosine-protein kinase erbB-4 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL226345 |
CHEMBL1819990
(1)
|
0 / 0 |
| O14965 | Aurora kinase A | Aur | CHEMBL226345 |
CHEMBL1819984
(1)
|
0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | CHEMBL226345 |
CHEMBL1614544
(1)
|
11 / 10 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL226345 |
CHEMBL905368
(1)
CHEMBL905369
(1)
|
1 / 1 |
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL226345 |
CHEMBL1820091
(1)
|
0 / 0 |
| P06493 | Cyclin-dependent kinase 1 | Cdc2 | CHEMBL226345 |
CHEMBL657992
(1)
|
0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL226345 |
CHEMBL1819987
(1)
|
1 / 11 |
| P31751 | RAC-beta serine/threonine-protein kinase | Akt | CHEMBL226345 |
CHEMBL1819982
(1)
|
2 / 2 |
| O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | CHEMBL226345 |
CHEMBL1819977
(1)
|
0 / 0 |
| Q13464 | Rho-associated protein kinase 1 | Rock | CHEMBL226345 |
CHEMBL831996
(1)
CHEMBL1820093
(1)
|
0 / 0 |
| O43353 | Receptor-interacting serine/threonine-protein kinase 2 | Ripk | CHEMBL226345 |
CHEMBL1820092
(1)
|
0 / 0 |
| P07332 | Tyrosine-protein kinase Fes/Fps | Fer | CHEMBL226345 |
CHEMBL1819988
(1)
|
0 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL226345 |
CHEMBL831995
(1)
CHEMBL1819992
(1)
|
0 / 0 |
| Q05397 | Focal adhesion kinase 1 | Fak | CHEMBL226345 |
CHEMBL1819991
(1)
|
0 / 0 |
| P03956 | Interstitial collagenase | M10A | CHEMBL226345 |
CHEMBL1664431
(1)
|
0 / 1 |
| Q99683 | Mitogen-activated protein kinase kinase kinase 5 | Ste11 | CHEMBL226345 |
CHEMBL1819983
(1)
|
0 / 0 |
| P15056 | Serine/threonine-protein kinase B-raf | Raf | CHEMBL226345 |
CHEMBL1819986
(1)
|
6 / 3 |
| Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | CHEMBL226345 |
CHEMBL1738574
(1)
|
0 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL226345 |
CHEMBL1819989
(1)
|
5 / 10 |
| Q96GD4 | Aurora kinase B | Aur | CHEMBL226345 |
CHEMBL1819985
(1)
|
0 / 0 |
| P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL226345 |
CHEMBL1819996
(1)
|
0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL226345 |
CHEMBL832022
(1)
|
0 / 0 |
| P45983 | Mitogen-activated protein kinase 8 | Jnk | CHEMBL226345 |
CHEMBL832005
(1)
CHEMBL1819979
(1)
|
0 / 0 |
| P08253 | 72 kDa type IV collagenase | M10A | CHEMBL226345 |
CHEMBL1664432
(1)
|
1 / 3 |
| Q13177 | Serine/threonine-protein kinase PAK 2 | STE serine/threonine protein kinase PAKA subfamily | CHEMBL226345 |
CHEMBL1820087
(1)
|
0 / 0 |
| Q08881 | Tyrosine-protein kinase ITK/TSK | Tec | CHEMBL226345 |
CHEMBL1819994
(1)
|
1 / 1 |
| O00329 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Enzyme | CHEMBL226345 |
CHEMBL1820090
(1)
|
0 / 0 |
| P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | CHEMBL226345 |
CHEMBL1028564
(1)
|
0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL226345 |
CHEMBL830592
(1)
CHEMBL1819981
(1)
|
4 / 1 |
| Q15118 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial | Pdhk | CHEMBL226345 |
CHEMBL1820088
(1)
|
0 / 0 |
| O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | CHEMBL226345 |
CHEMBL1820094
(1)
|
0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL226345 |
CHEMBL1738184
(1)
|
0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL226345 |
CHEMBL832023
(1)
|
0 / 1 |
| P52333 | Tyrosine-protein kinase JAK3 | Jakb | CHEMBL226345 |
CHEMBL1819995
(1)
|
1 / 1 |
| P04049 | RAF proto-oncogene serine/threonine-protein kinase | Raf | CHEMBL226345 |
CHEMBL832054
(1)
|
2 / 0 |
| P43405 | Tyrosine-protein kinase SYK | Syk | CHEMBL226345 |
CHEMBL1820095
(1)
|
0 / 0 |
| P08254 | Stromelysin-1 | M10A | CHEMBL226345 |
CHEMBL1664433
(1)
|
1 / 0 |
| P48736 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Enzyme | CHEMBL226345 |
CHEMBL1819978
(1)
|
0 / 0 |
| P22694 | cAMP-dependent protein kinase catalytic subunit beta | Pka | CHEMBL226345 |
CHEMBL831286
(1)
|
0 / 0 |
| P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL226345 |
CHEMBL831286
(1)
|
0 / 0 |
| P22612 | cAMP-dependent protein kinase catalytic subunit gamma | Pka | CHEMBL226345 |
CHEMBL831286
(1)
|
0 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | CHEMBL226345 |
CHEMBL2354287
(1)
|
1 / 1 |
CTD interaction (1)
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| D000225 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Adenine inhibits the reaction [deoxynivalenol results in increased expression of IL8 protein] |
decreases reaction
/ increases expression |
protein |
18308354
|
Related Disease
Diseases related to proteins in ChEMBL interactions
OMIM (44)
| OMIM | preferred title | UniProt |
|---|---|---|
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #114480 | Breast cancer |
P31749
P42336 |
| #115150 | Cardiofaciocutaneous syndrome 1; cfc1 |
P15056
|
| #615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P15056
P31749 P42336 |
| #612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #615108 | Cowden syndrome 5; cws5 |
P42336
|
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P31751
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #114550 | Hepatocellular carcinoma |
P42336
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
| #270450 | Insulin-like growth factor i, resistance to |
P08069
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #182000 | Keratosis, seborrheic |
P42336
|
| #611554 | Leopard syndrome 2 |
P04049
|
| #613707 | Leopard syndrome 3 |
P15056
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #211980 | Lung cancer |
P00533
P04626 P15056 |
| #605027 | Lymphoma, non-hodgkin, familial |
P15056
|
| #613011 | Lymphoproliferative syndrome 1; lpfs1 |
Q08881
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
| #603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #611553 | Noonan syndrome 5; ns5 |
P04049
|
| #613706 | Noonan syndrome 7; ns7 |
P15056
|
| #167000 | Ovarian cancer |
P04626
P42336 |
| #176920 | Proteus syndrome |
P31749
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #600802 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative |
P52333
|
| #278300 | Xanthinuria, type i |
P47989
|
KEGG DISEASE (38)
| KEGG | disease name | UniProt |
|---|---|---|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
|
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P08253 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00026 | Endometrial Cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
P31751 (related) P42336 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00015 | Malignant pleural mesothelioma |
P08069
(related)
|
| H00050 | Synovial sarcoma |
P08069
(related)
|
| H01274 | Growth delay due to insulin-like growth factor I resistance |
P08069
(related)
|
| H00025 | Penile cancer |
P08253
(related)
P14780 (related) |
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00032 | Thyroid cancer |
P15056
(related)
|
| H00038 | Malignant melanoma |
P15056
(related)
|
| H00523 | Noonan syndrome and related disorders |
P15056
(related)
Q02750 (related) |
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P52333
(related)
|
| H00107 | Other well-defined immunodeficiency syndromes |
Q08881
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
Diseases related to CTD interactions
6 disease from interactions of metabolites
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D000855 | D000225 | Anorexia |
marker/mechanism
|
946274
|
|
| D002779 | D000225 | Cholestasis |
marker/mechanism
|
946274
|
|
| D056486 | D000225 | Drug-Induced Liver Injury |
marker/mechanism
|
946274
|
|
| D007565 | D000225 | Jaundice |
marker/mechanism
|
946274
|
|
| D009325 | D000225 | Nausea |
marker/mechanism
|
946274
|
|
| D051437 | D000225 | Renal Insufficiency |
marker/mechanism
|
11758903
|